Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitral Valve Insufficiency | 5 | 2022 | 95 | 2.140 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2022 | 176 | 1.940 |
Why?
|
| Cardiac Catheterization | 9 | 2022 | 292 | 1.120 |
Why?
|
| Aortic Valve Stenosis | 3 | 2020 | 190 | 1.040 |
Why?
|
| Heart Valve Prosthesis | 4 | 2022 | 114 | 0.940 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2020 | 112 | 0.710 |
Why?
|
| Thrombosis | 2 | 2015 | 198 | 0.670 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2020 | 10 | 0.660 |
Why?
|
| Liver Diseases | 1 | 2021 | 160 | 0.630 |
Why?
|
| Capecitabine | 1 | 2019 | 15 | 0.620 |
Why?
|
| Myocarditis | 1 | 2020 | 70 | 0.610 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 42 | 0.610 |
Why?
|
| Aortic Valve | 4 | 2020 | 190 | 0.600 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2019 | 66 | 0.570 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 248 | 0.560 |
Why?
|
| Hemorrhage | 2 | 2010 | 275 | 0.560 |
Why?
|
| Catheterization, Peripheral | 1 | 2018 | 49 | 0.540 |
Why?
|
| Treatment Outcome | 11 | 2022 | 5697 | 0.540 |
Why?
|
| Cardiac Catheters | 1 | 2015 | 12 | 0.470 |
Why?
|
| Ambulatory Care | 1 | 2018 | 317 | 0.460 |
Why?
|
| Heart Valve Diseases | 3 | 2022 | 95 | 0.450 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 439 | 0.440 |
Why?
|
| Patient Discharge | 1 | 2018 | 507 | 0.420 |
Why?
|
| Thrombectomy | 1 | 2015 | 242 | 0.390 |
Why?
|
| Mitral Valve | 4 | 2022 | 127 | 0.370 |
Why?
|
| Mitral Valve Stenosis | 2 | 2022 | 16 | 0.330 |
Why?
|
| Hemostatic Techniques | 1 | 2010 | 11 | 0.320 |
Why?
|
| Popliteal Artery | 1 | 2010 | 24 | 0.310 |
Why?
|
| Calcinosis | 2 | 2022 | 86 | 0.310 |
Why?
|
| Angioplasty, Balloon | 1 | 2010 | 54 | 0.310 |
Why?
|
| Embolism | 1 | 2010 | 41 | 0.300 |
Why?
|
| Femoral Artery | 1 | 2010 | 99 | 0.290 |
Why?
|
| Coronary Angiography | 3 | 2019 | 209 | 0.290 |
Why?
|
| Humans | 19 | 2022 | 64279 | 0.260 |
Why?
|
| Risk Factors | 5 | 2021 | 5342 | 0.220 |
Why?
|
| Hemodynamics | 3 | 2022 | 249 | 0.220 |
Why?
|
| Aged | 6 | 2022 | 14664 | 0.180 |
Why?
|
| Equipment Design | 2 | 2015 | 362 | 0.180 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 5528 | 0.170 |
Why?
|
| Myocardial Infarction | 2 | 2022 | 915 | 0.170 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2018 | 113 | 0.160 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 59 | 0.160 |
Why?
|
| Female | 9 | 2022 | 33382 | 0.160 |
Why?
|
| Prosthesis Design | 1 | 2020 | 224 | 0.160 |
Why?
|
| Anus Neoplasms | 1 | 2019 | 25 | 0.150 |
Why?
|
| Balloon Valvuloplasty | 2 | 2018 | 14 | 0.150 |
Why?
|
| Male | 7 | 2022 | 30323 | 0.150 |
Why?
|
| Chest Pain | 1 | 2019 | 84 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2020 | 189 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 180 | 0.140 |
Why?
|
| Hospitals | 1 | 2021 | 390 | 0.140 |
Why?
|
| Echocardiography, Doppler | 1 | 2019 | 133 | 0.140 |
Why?
|
| Middle Aged | 6 | 2020 | 17923 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2018 | 577 | 0.120 |
Why?
|
| Patient Safety | 1 | 2018 | 243 | 0.110 |
Why?
|
| Radionuclide Ventriculography | 1 | 2014 | 5 | 0.110 |
Why?
|
| Time Factors | 3 | 2018 | 3726 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2019 | 1301 | 0.110 |
Why?
|
| Length of Stay | 1 | 2018 | 819 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2018 | 2049 | 0.110 |
Why?
|
| Multimodal Imaging | 1 | 2014 | 71 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1561 | 0.110 |
Why?
|
| Heart Failure | 1 | 2022 | 926 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2018 | 432 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 165 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2014 | 265 | 0.100 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 271 | 0.100 |
Why?
|
| Massachusetts | 1 | 2018 | 2096 | 0.090 |
Why?
|
| Fibroma | 1 | 2011 | 14 | 0.090 |
Why?
|
| Heart Neoplasms | 1 | 2011 | 36 | 0.080 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2010 | 12 | 0.080 |
Why?
|
| Thiophenes | 1 | 2010 | 30 | 0.080 |
Why?
|
| Young Adult | 1 | 2020 | 4781 | 0.080 |
Why?
|
| Ticlopidine | 1 | 2010 | 49 | 0.080 |
Why?
|
| Piperazines | 1 | 2010 | 87 | 0.080 |
Why?
|
| Punctures | 1 | 2010 | 63 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2218 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2020 | 6742 | 0.080 |
Why?
|
| Pyridines | 1 | 2010 | 114 | 0.080 |
Why?
|
| Aspirin | 1 | 2010 | 172 | 0.070 |
Why?
|
| Sympathomimetics | 1 | 2008 | 5 | 0.070 |
Why?
|
| Dobutamine | 1 | 2008 | 11 | 0.070 |
Why?
|
| Echocardiography, Stress | 1 | 2008 | 14 | 0.070 |
Why?
|
| Shock | 1 | 2008 | 32 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 233 | 0.070 |
Why?
|
| Pheochromocytoma | 1 | 2008 | 31 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2010 | 297 | 0.070 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2008 | 49 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 553 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 244 | 0.070 |
Why?
|
| Acute Coronary Syndrome | 1 | 2010 | 253 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 460 | 0.060 |
Why?
|
| Coronary Restenosis | 1 | 2006 | 20 | 0.060 |
Why?
|
| Respiratory Insufficiency | 1 | 2008 | 154 | 0.060 |
Why?
|
| Metals | 1 | 2006 | 64 | 0.060 |
Why?
|
| Adult | 1 | 2020 | 17133 | 0.050 |
Why?
|
| Stents | 1 | 2006 | 493 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 2022 | 104 | 0.040 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2018 | 45 | 0.030 |
Why?
|
| Suture Techniques | 1 | 2018 | 100 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 286 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2018 | 870 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2014 | 330 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1105 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 1669 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 1769 | 0.020 |
Why?
|
| Exercise Test | 1 | 2011 | 254 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 449 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2008 | 125 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2011 | 270 | 0.020 |
Why?
|
| United States | 1 | 2018 | 7923 | 0.010 |
Why?
|